MediPharm Labs Corp. (TSX:LABS)

MediPharm Labs Statistics

Total Valuation

MediPharm Labs has a market cap or net worth of CAD 31.56 million. The enterprise value is 21.46 million.

Market Cap	31.56M
Enterprise Value	21.46M

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

MediPharm Labs has 420.76 million shares outstanding. The number of shares has increased by 3.50% in one year.

Current Share Class	420.76M
Shares Outstanding	420.76M
Shares Change (YoY)	+3.50%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	8.72%
Owned by Institutions (%)	0.00%
Float	384.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.71
PB Ratio	0.79
P/TBV Ratio	0.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.48
EV / Sales	0.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.80

Financial Position

The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.01.

Current Ratio	3.11
Quick Ratio	1.97
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-24.83

Financial Efficiency

Return on equity (ROE) is -19.80% and return on invested capital (ROIC) is -9.71%.

Return on Equity (ROE)	-19.80%
Return on Assets (ROA)	-8.08%
Return on Invested Capital (ROIC)	-9.71%
Return on Capital Employed (ROCE)	-17.71%
Revenue Per Employee	276,112
Profits Per Employee	-53,770
Employee Count	161
Asset Turnover	0.81
Inventory Turnover	3.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.39% in the last 52 weeks. The beta is 0.41, so MediPharm Labs's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	+15.39%
50-Day Moving Average	0.07
200-Day Moving Average	0.08
Relative Strength Index (RSI)	52.25
Average Volume (20 Days)	370,093

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MediPharm Labs had revenue of CAD 44.45 million and -8.66 million in losses. Loss per share was -0.02.

Revenue	44.45M
Gross Profit	14.60M
Operating Income	-7.05M
Pretax Income	-8.66M
Net Income	-8.66M
EBITDA	-5.21M
EBIT	-7.05M
Loss Per Share	-0.02

Balance Sheet

The company has 10.64 million in cash and 542,000 in debt, giving a net cash position of 10.10 million or 0.02 per share.

Cash & Cash Equivalents	10.64M
Total Debt	542,000
Net Cash	10.10M
Net Cash Per Share	0.02
Equity (Book Value)	39.82M
Book Value Per Share	0.09
Working Capital	20.04M

Cash Flow

In the last 12 months, operating cash flow was -7.51 million and capital expenditures -161,000, giving a free cash flow of -7.67 million.

Operating Cash Flow	-7.51M
Capital Expenditures	-161,000
Free Cash Flow	-7.67M
FCF Per Share	-0.02

Margins

Gross margin is 32.84%, with operating and profit margins of -15.86% and -19.47%.

Gross Margin	32.84%
Operating Margin	-15.86%
Pretax Margin	-19.47%
Profit Margin	-19.47%
EBITDA Margin	-11.72%
EBIT Margin	-15.86%
FCF Margin	n/a

Dividends & Yields

MediPharm Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.50%
Shareholder Yield	n/a
Earnings Yield	-27.43%
FCF Yield	-24.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MediPharm Labs has an Altman Z-Score of -2.45 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.45
Piotroski F-Score	3